NCT01274000View on ClinicalTrials.gov

A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

YM060

oral

DRUG

placebo

oral

Trial Locations (4)

Unknown

Hokkaido

Kansai

Kantou

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY